Thermo Fisher Scientific Inc. has introduced Gibco Bacto CD Supreme FPM Plus and Gibco Bacto CD Supreme Feed (2X).
First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...
According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco™ Bacto™ CD Supreme FPM Plus and Gibco™ Bacto™ CD Supreme Feed (2X), two next-generation ...
A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the ...
The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.
Newborn babies admitted to the hospital's neonatal intensive care unit (NICU) rely on the quick decisions and rapid action of the medical team responsible for them. DNA testing is critical to ...
13don MSN
Adjustable DNA 'shield' can control timing and rate at which mRNA produces proteins in vivo
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...
To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback